Jun Wu

ORCID: 0000-0002-0008-9434 · 5 papers in corpus
other 2025
Suture Fixation of Levonorgestrel-Releasing Device Using the Hysteroscopic Surgery System
JSLS : Journal of the Society of Laparoendoscopic Surgeons ·doi:10.4293/JSLS.2024.00076

BACKGROUND: The levonorgestrel-releasing intrauterine system (LNG-IUS) is a widely recognized method for contraception and the management of various gynecological conditions. However, the placement of LNG-IUS can be particularly challenging…

article 2025
Value of contrast-enhanced ultrasound in evaluating blood flow perfusion changes in adenomyosis patients treated with HIFU combined with leuprorelin
Current problems in surgery ·doi:10.1016/j.cpsurg.2025.101898

To investigate the clinical application value of contrast-enhanced ultrasound (CEUS) technology in evaluating blood flow perfusion changes in adenomyosis patients treated with high-intensity focused ultrasound (HIFU) combined with leuprorel…

article 2020
MTA1, a Target of Resveratrol, Promotes Epithelial-Mesenchymal Transition of Endometriosis via ZEB2
Molecular therapy. Methods & clinical development ·doi:10.1016/j.omtm.2020.09.013

Endometriosis is a benign disease that shares some malignant features. Epithelial-mesenchymal transition (EMT) is involved in the pathogenesis of endometriosis. Metastasis-associated protein 1 (MTA1) plays an important role in various cance…

article 2020
MTA1 Is Up-Regulation Expression in Endometriosis and Promotesepithelial-Mesenchymal Transition of Endometriosis via ZEB2
·doi:10.2139/ssrn.3537066
other 2020
Three-dimensional oxabicycloheptene sulfonate targets the homologous recombination and repair programmes through estrogen receptor α antagonism
Cancer letters ·doi:10.1016/j.canlet.2019.10.019

Selective estrogen receptor modulators (SERMs) are a class of structurally diverse compounds, which have been extensively used to treat hormone-responsive cancers due to their unique partially agonistic and antagonistic properties toward es…